title: The results of imatinib therapy for patients with primary eosinophilic disorders.
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Helbig
authors.forename: Beata
authors.initials: B
authors.lastname: Stella-Holowiecka
authors.forename: Sebastian
authors.initials: S
authors.lastname: Grosicki
authors.forename: Grazyna
authors.initials: G
authors.lastname: Bober
authors.forename: Magorzata
authors.initials: M
authors.lastname: Krawczyk
authors.forename: Jerzy
authors.initials: J
authors.lastname: Wojnar
authors.forename: Andreas
authors.initials: A
authors.lastname: Reiter
authors.forename: Andreas
authors.initials: A
authors.lastname: Hochhaus
authors.forename: Jerzy
authors.initials: J
authors.lastname: Holowiecki
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D004341:Drug Evaluation; D004802:Eosinophilia / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000235:genetics; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000188:drug therapy; D009363:Neoplasm Proteins / Q000032:analysis / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000032:analysis / Q000235:genetics; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000032:analysis / Q000235:genetics; D016896:Treatment Outcome; D039221:mRNA Cleavage and Polyadenylation Factors / Q000032:analysis / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha